Unveiling a novel function of Aconitase-2: attenuating lung ischemia-reperfusion injury via inhibition of pulmonary endothelial apoptosis
Redox Biology · 2026
DOI: 10.1016/j.redox.2026.104016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Redox Biology, 2026. Verfasst von Jiaojiao Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu, 214122, China; Department of Anesthesiology, The Affiliated Wuxi Peopl…. Hauptthemen laut MEDLINE: Reperfusion Injury, Apoptosis, Aconitate Hydratase, Endothelial Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Graduate Research and Innovation Projects of Jiangsu Province, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Mitochondrial dysfunction during lung ischemia-reperfusion injury (LIRI) contributes to organ dysfunction. Aconitase-2 (ACO2), by enhancing the mitochondrial tricarboxylic acid (TCA) cycle in pulmonary vascular endothelial cells (PVECs), plays a critical role in maintaining cellular energy metabolic homeostasis. Single-cell RNA sequencing was performed to characterize cellular phenotypes within the lung tissue microenvironment of I/R mice, and bulk RNA sequencing was applied to identify differentially expressed genes associated with LIRI. Our clinical cohort included 65 healthy donors and 48 patients with LIRI to evaluate the correlation between serum ACO2 levels and lung function. In vivo, using a murine I/R model, we administered an adeno-associated virus for lung-specific ACO2 overexpression, as well as an ACO2 inhibitor (tricarballylic acid), to assess their effects on lung injury. In vitro, primary PVECs were isolated and subjected to hypoxia/reoxygenation (H/R), followed by ACO2 overexpression or knockout, and treatment with the ACO2 downstream metabolite derivative 4-octyl itaconate (4-OI), to investigate its role in mitochondrial function and apoptosis. Serum ACO2 levels were reduced in LIRI patients and exhibited a significant negative correlation with impaired lung function. In I/R mice, ACO2 overexpression ameliorated mitochondrial dysfunction and attenuated lung injury, whereas ACO2 inhibition exacerbated these pathological changes. In PVECs, ACO2 overexpression enhanced mitochondrial function and reduced apoptosis; conversely, ACO2 knockout exerted opposing effects. Notably, supplementation with 4-OI mitigated mitochondrial dysfunction and cellular apoptosis induced by ACO2 deficiency. These findings suggest that ACO2 has therapeutic potential in improving mitochondrial function, reducing apoptosis, and alleviating LIRI, positioning it as a promising target for the treatment of this condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu, 214122, China; Department of Anesthesiology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wu…
- Department of Anesthesiology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, 299 Qingyang Road, Wuxi, Jiangsu, 214023, China.
- Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu, 214122, China.
- Department of Anesthesiology, First Hospital of Jilin University, 1 Xinmin Street, Changchun, Jilin, 130000, China.
- Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu, 214122, China. Electronic address: qfpang@jiangnan.edu.cn.
- Department of Anesthesiology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, 299 Qingyang Road, Wuxi, Jiangsu, 214023, China…
Förderung
- Graduate Research and Innovation Projects of Jiangsu Province
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Nanjing Medical University
Zitieren
APA
Sun, J., Xu, B., Chen, Y., Sui, M., Wang, M., Ma, R., Wu, J., Teng, S., Pang, Q., & Hu, C. (2026). Unveiling a novel function of Aconitase-2: attenuating lung ischemia-reperfusion injury via inhibition of pulmonary endothelial apoptosis. Redox Biology. https://doi.org/10.1016/j.redox.2026.104016
Vancouver
Sun J, Xu B, Chen Y, Sui M, Wang M, Ma R, et al. Unveiling a novel function of Aconitase-2: attenuating lung ischemia-reperfusion injury via inhibition of pulmonary endothelial apoptosis. Redox Biology. 2026. doi:10.1016/j.redox.2026.104016
BibTeX
@article{Sun2026,
author = {Sun, Jiaojiao and Xu, Bo and Chen, Yijing and Sui, Meng and Wang, Mochi and Ma, Ranming and Wu, Jinbo and Teng, Shiyong and Pang, Qingfeng and Hu, Chunxiao},
title = {Unveiling a novel function of Aconitase-2: attenuating lung ischemia-reperfusion injury via inhibition of pulmonary endothelial apoptosis},
journal = {Redox Biology},
year = {2026},
doi = {10.1016/j.redox.2026.104016}
}
EUVIMED